Risk assessment tools for identifying individuals at risk of developing type 2 diabetes - PubMed (original) (raw)
Review
Risk assessment tools for identifying individuals at risk of developing type 2 diabetes
Brian Buijsse et al. Epidemiol Rev. 2011.
Abstract
Trials have demonstrated the preventability of type 2 diabetes through lifestyle modifications or drugs in people with impaired glucose tolerance. However, alternative ways of identifying people at risk of developing diabetes are required. Multivariate risk scores have been developed for this purpose. This article examines the evidence for performance of diabetes risk scores in adults by 1) systematically reviewing the literature on available scores and 2) their validation in external populations; and 3) exploring methodological issues surrounding the development, validation, and comparison of risk scores. Risk scores show overall good discriminatory ability in populations for whom they were developed. However, discriminatory performance is more heterogeneous and generally weaker in external populations, which suggests that risk scores may need to be validated within the population in which they are intended to be used. Whether risk scores enable accurate estimation of absolute risk remains unknown; thus, care is needed when using scores to communicate absolute diabetes risk to individuals. Several risk scores predict diabetes risk based on routine noninvasive measures or on data from questionnaires. Biochemical measures, in particular fasting plasma glucose, can improve prediction of such models. On the other hand, usefulness of genetic profiling currently appears limited.
Figures
Figure 1.
Identification of studies included in the review.
Similar articles
- Cardiovascular risk assessment scores for people with diabetes: a systematic review.
Chamnan P, Simmons RK, Sharp SJ, Griffin SJ, Wareham NJ. Chamnan P, et al. Diabetologia. 2009 Oct;52(10):2001-14. doi: 10.1007/s00125-009-1454-0. Epub 2009 Jul 24. Diabetologia. 2009. PMID: 19629430 Free PMC article. Review. - Risk models and scores for type 2 diabetes: systematic review.
Noble D, Mathur R, Dent T, Meads C, Greenhalgh T. Noble D, et al. BMJ. 2011 Nov 28;343:d7163. doi: 10.1136/bmj.d7163. BMJ. 2011. PMID: 22123912 Free PMC article. Review. - Two risk score models for predicting incident Type 2 diabetes in Japan.
Doi Y, Ninomiya T, Hata J, Hirakawa Y, Mukai N, Iwase M, Kiyohara Y. Doi Y, et al. Diabet Med. 2012 Jan;29(1):107-14. doi: 10.1111/j.1464-5491.2011.03376.x. Diabet Med. 2012. PMID: 21718358 - Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
Slieker RC, van der Heijden AAWA, Siddiqui MK, Langendoen-Gort M, Nijpels G, Herings R, Feenstra TL, Moons KGM, Bell S, Elders PJ, 't Hart LM, Beulens JWJ. Slieker RC, et al. BMJ. 2021 Sep 28;374:n2134. doi: 10.1136/bmj.n2134. BMJ. 2021. PMID: 34583929 Free PMC article. - Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score.
Tuomilehto J, Lindström J, Hellmich M, Lehmacher W, Westermeier T, Evers T, Brückner A, Peltonen M, Qiao Q, Chiasson JL. Tuomilehto J, et al. Diabetes Res Clin Pract. 2010 Feb;87(2):267-74. doi: 10.1016/j.diabres.2009.11.011. Epub 2009 Dec 22. Diabetes Res Clin Pract. 2010. PMID: 20022651
Cited by
- Pros and cons of live kidney donation in prediabetics: A critical review and way forward.
Khalil MAM, Sadagah NM, Tan J, Syed FO, Chong VH, Al-Qurashi SH. Khalil MAM, et al. World J Transplant. 2024 Mar 18;14(1):89822. doi: 10.5500/wjt.v14.i1.89822. World J Transplant. 2024. PMID: 38576756 Free PMC article. Review. - Life's Essential 8 and osteoporosis in adults aged 50 years or older: data from the National Health and Nutrition Examination Survey.
Tang Y, Dong W, Shen J, Jiang G, Wang Q, Hao J, Hu Z. Tang Y, et al. Arch Osteoporos. 2024 Feb 16;19(1):13. doi: 10.1007/s11657-024-01368-5. Arch Osteoporos. 2024. PMID: 38363413 - Validation of prevalent diabetes risk scores based on non-invasively measured predictors in Ghanaian migrant and non-migrant populations - The RODAM study.
Osei-Yeboah J, Kengne AP, Owusu-Dabo E, Schulze MB, Meeks KAC, Klipstein-Grobusch K, Smeeth L, Bahendeka S, Beune E, Moll van Charante EP, Agyemang C. Osei-Yeboah J, et al. Public Health Pract (Oxf). 2023 Nov 23;6:100453. doi: 10.1016/j.puhip.2023.100453. eCollection 2023 Dec. Public Health Pract (Oxf). 2023. PMID: 38034345 Free PMC article. - Family Involvement to Stop the Conversion of Prediabetes to Diabetes.
Prakoso DA, Mahendradhata Y, Istiono W. Prakoso DA, et al. Korean J Fam Med. 2023 Nov;44(6):303-310. doi: 10.4082/kjfm.23.0019. Epub 2023 Aug 14. Korean J Fam Med. 2023. PMID: 37582666 Free PMC article. - Workload and workflow implications associated with the use of electronic clinical decision support tools used by health professionals in general practice: a scoping review.
Fletcher E, Burns A, Wiering B, Lavu D, Shephard E, Hamilton W, Campbell JL, Abel G. Fletcher E, et al. BMC Prim Care. 2023 Jan 20;24(1):23. doi: 10.1186/s12875-023-01973-2. BMC Prim Care. 2023. PMID: 36670354 Free PMC article. Review.
References
- Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002;359(9323):2072–2077. - PubMed
- DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators. Gerstein HC, Yusuf S, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 2006;368(9541):1096–1105. - PubMed
- Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008;371(9626):1783–1789. - PubMed
- Lindström J, Ilanne-Parikka P, Peltonen M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368(9548):1673–1679. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical